ArticleVaccines2021

Recombinant Antigens Based on Non-Glycosylated Regions from RBD SARS-CoV-2 as Potential Vaccine Candidates against COVID-19.

Leandro Núñez-Muñoz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.